Companies

GoodRx Holdings, Inc.

GDRX · CIK 0001809519 · operating

$2.17+16.04%Last updated Mar 3, 12:52 AM

Key Statistics

Valuation

Market Cap$753.97M
P/E27.13
Fwd P/E5.31
PEG
P/S0.95
P/B1.20
EV/EBITDA5.30
EV/Rev1.28

Profitability

Gross Margin
Op. Margin10.98%
Net Margin3.82%
ROE4.94%
ROA2.17%
FCF Margin20.63%

Financial Health

Current Ratio2.61
Debt/Equity1.28
Free Cash Flow$164.38M
Div. Yield

Growth & Other

Revenue Growth0.57%
EPS Growth125.00%
Beta1.56
52W High$5.81
52W Low$1.77

About GoodRx Holdings, Inc.

# GoodRx Holdings, Inc.

GoodRx operates a digital platform enabling U.S. consumers to compare prescription drug prices across pharmacies and access negotiated pricing. The company's core offering provides price transparency tools that allow consumers to identify lower-cost alternatives and generate discount codes or coupons at participating pharmacies. Beyond price comparison, GoodRx has expanded into adjacent healthcare services, including GoodRx Care, a telehealth platform offering virtual consultations, and pet health products for dogs, cats, and other animals.

The company generates revenue through multiple streams. Its primary business involves partnerships with pharmacy benefit managers who utilize GoodRx's platform to manage formularies and prescription transactions. The company also derives revenue from subscription offerings and solutions provided to pharmaceutical manufacturers. GoodRx Care contributes telehealth service revenue, while its pet health division represents a supplementary business segment.

Based in Santa Monica, California, GoodRx was founded in 2011 and operates primarily within the United States market. The company serves a broad consumer base seeking prescription cost reduction alongside institutional clients in pharmacy and pharma sectors. The platform's reach extends across the U.S. pharmacy network, enabling price comparisons and discounts at major chains and independent pharmacies.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$0.09$0.09+125.0%
2024$0.04$0.04+300.0%
2023$-0.02$-0.02+75.0%
2022$-0.08$-0.08-33.3%
2021$-0.06$-0.06+94.4%
2020$-1.07$-1.07

Annual Reports (10-K) · 6 filings

Report DateFiledAccession Number
2025-12-312026-02-260001809519-26-000031SEC ↗
2024-12-312025-02-270001809519-25-000040SEC ↗
2023-12-312024-02-290001809519-24-000032SEC ↗
2022-12-312023-03-010000950170-23-005262SEC ↗
2021-12-312022-03-010000950170-22-002348SEC ↗
2020-12-312021-03-120001564590-21-012614SEC ↗